Eli Lilly targets FDA approval for weight loss medication |
New COVID-19 variant with high transmissibility identified |
CMS to punish hospitals sooner for price transparency noncompliance |
Walmart Health expands to Oklahoma |
Kaiser Permanente acquiring Geisinger, launching new nonprofit |
Movers & Shakers: Kaiser Permanente, Corewell Health, Allina Health name new leadership |
Conifer, Welldoc partner in digital health app |
Global healthcare partnership targets ‘the big catch-up’ vaccination initiative |
Florida surgeon general altered COVID-19 study findings |
Health editors quit in protest over high publishing charges |
Supreme Court upholds full access to abortion pill |
Seema Verma, former CMS head, joins Oracle |
Infusion system recalled for possible leaks after multiple complaints |
OTC Narcan will cost less than $50 |
Judge halts all lawsuits related to J&J talc formula |
DOJ targets COVID-related healthcare fraud |
GE Healthcare solution, billed as a 'unified approach to patient monitoring,' gains FDA clearance |
Supreme Court delays final decision on abortion pill for 2 more days |
CVS Health names former Humana exec the new president of Aetna |
FDA announces shift to simplify COVID-19 vaccines |
Hospital CEO exits on the rise again |
Phillips partners with Amazon to host EI offering, advance AI tools |
Poverty is a leading cause of death |
Merck to acquire Prometheus Biosciences for $10.8B |
Cano Health separates leadership roles following board member exits |
Moderna, Merck say new combination treatment boosts skin cancer survival |
Supreme Court halts restrictions on abortion pill |
Outcome Health execs convicted in $1B fraud scheme |
DOJ to appeal abortion pill case to Supreme Court |
Movers & Shakers: CEO changes at Johns Hopkins/UMMS, Central Health |
Political climate leads to loss of labor and delivery services |
Sanofi’s $2.9B acquisition of Provention Bio delayed by FTC review |
Sexually transmitted infections are on the rise, warns CDC |
CMS proposes 2.8% rate increase for inpatient payments in 2024 |
Drugmakers condemn judge’s suspension of abortion pill access |
Best and worst states for children’s healthcare |
Private equity in healthcare: Deals decreased in 2022, but market was still active |
Healthcare leaders make list of world's richest people |
Abortion pill legality in question after conflicting federal judgments |
Serious patient safety events up 19% in 2022 |
Medtronic, DaVita launch new kidney health company |
Industry groups applaud bill connecting Medicare payments to inflation |
These health systems have the biggest digital health portfolios |
Cano Health leadership team in disarray after directors resign |
$300M research fund will focus on Alzheimer’s |
Johnson & Johnson offers nearly $9B to settle talc lawsuits |
Liver specialists among first to be ably aided by ChatGPT |
Too much too soon? Elon Musk, other tech leaders pause AI development to review ethics |
The healthiest and unhealthiest US cities |
Illumina ordered to divest Grail |
CMS finalizes 2024 MA payment rule with rate bump |
FDA turns up sterility issues at eye drop facility linked to deaths, vision loss |